[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100553217":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":54,"collaborators":12,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":12,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":12,"enrollmentInfo":66,"targetDuration":12,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":78,"overallStatus":88,"whyStopped":12,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Louisiana State University Health Sciences Center in New Orleans","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard of care","NO_INTERVENTION","Standard 6 month post-operative follow up interval for repeat injection",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Patient-directed follow up","EXPERIMENTAL","Post-operative follow up interval for repeat injection decided by patient based on OAB symptomatology (3-12 months)",[18],"Behavioral: Patient-directed follow up",[20],{"type":21,"name":14,"description":22,"armGroupLabels":23,"otherNames":12},"BEHAVIORAL","Patients will be instructed to follow up for repeat injection based on bladder symptomatology at their own self-determined time interval.",[14],[25],{"name":26,"affiliation":27,"role":28},"Lisa Peacock, MD","Louisiana State University Health Science Center - New Orleans","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":12,"email":34},"Zachary Selzler, MD","CONTACT","504-568-2383","zselzl@lsuhsc.edu",[36],{"facility":37,"status":12,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Louisiana State University Health Science Center","New Orleans","Louisiana","70112","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-90.07507,29.95465,{"lat":47,"lon":46},[50,51,53],{"name":31,"role":32,"phone":33,"phoneExt":12,"email":34},{"name":31,"role":52,"phone":12,"phoneExt":12,"email":12},"SUB_INVESTIGATOR",{"name":26,"role":28,"phone":12,"phoneExt":12,"email":12},{"type":28,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"Zachary S Selzler, MD","Zachary Selzler MD, Urogynecology Fellow","100553217","optimal-injection-interval-for-intra-detrusor-botulinum-toxin-100553217",false,"NCT06483217","Optimal Injection Interval for Intra-Detrusor Botulinum Toxin","Optimal Injection Interval for Intra-Detrusor Botulinum Toxin: A Randomized Controlled Trial Utilizing a Patient-Centered Approach","Inclusion Criteria:\n\n* diagnosis of overactive bladder, detrusor overactivity, urinary urgency, urinary frequency, nocturnal polyuria, or urge urinary incontinence\n* pursuing treatment with intravesical botulinum toxin injections\n\nExclusion Criteria:\n\n\\- non-OAB diagnosis such as pelvic pain or interstitial cystitis","FEMALE","18 Years",{"count":67,"type":68},100,"ESTIMATED","INTERVENTIONAL",[71],"NA","The goal of this clinical trial is to see if patients deciding their own follow up times can increase the effectiveness of botulinum toxin (BTX or \"Botox\") injection for overactive bladder (OAB). The main questions it aims to answer are:\n\n* Does the time between repeat injections differ from the 6-month standard when it is based on patient symptoms alone?\n* Does symptom control or patient satisfaction change when patients control their own follow up times?\n\nParticipants will undergo standard botulinum toxin injection into the bladder for OAB treatment and will then be randomly assigned to follow up either at a standard 6-month interval or whenever they feel their symptoms return.",[74,75,76,77],"Overactive Bladder","Urinary Urgency","Urinary Incontinence","Urge Urinary Incontinence",[79,80,81,82,83,84,85,86,87],"intradetrusor botulinum toxin","intravesical botox","intradetrusor botox","bladder chemodenervation","botox","chemodenervation","overactive bladder","urge urinary incontinence","intravesical botulinum toxin","NOT_YET_RECRUITING","2024-07-15",{"date":91,"type":92},"2024-07-17","ACTUAL",{"date":94,"type":68},"2024-07",{"date":96,"type":68},"2025-10",{"name":5,"class":6},1]